Ped. ALL Panel – Karyotyping and MLPA DeletionDuplication and FISH Panel Test
Cost: AED 4800.0
Welcome to the DNA Labs UAE blog! In this article, we will discuss the Ped. ALL Panel test, its components, cost, symptoms, diagnosis, and more.
Test Details
The Ped. ALL Panel is a diagnostic test used to detect genetic abnormalities in children with acute lymphoblastic leukemia (ALL). It includes three different tests:
- Karyotyping: This test examines the chromosomes in a patient’s cells to look for any abnormalities or changes in the number or structure of the chromosomes. It can detect large deletions or duplications of genetic material that may be associated with ALL.
- MLPA Deletion/Duplication Analysis: This test uses a specific technique called Multiplex Ligation-dependent Probe Amplification (MLPA) to detect smaller deletions or duplications of genetic material that may be missed by karyotyping. It can detect genetic abnormalities in specific genes known to be associated with ALL.
- FISH Panel Analysis: This test uses fluorescent probes to detect specific genetic abnormalities in the chromosomes of a patient’s cells. It can detect small changes in the DNA sequence that may be associated with ALL.
By combining these three tests, the Ped. ALL Panel provides a comprehensive analysis of a patient’s genetic makeup and helps identify any genetic abnormalities contributing to the development of ALL. This information can be used to guide treatment decisions and improve outcomes for children with this disease.
Test Components
The test requires EDTA & Sodium Heparin Vacutainer, with 2-3 ml of each component.
Price and Sample Condition
The Ped. ALL Panel test costs AED 4800.0. The sample condition required for this test is peripheral blood or bone marrow.
Report Delivery
The report for the Ped. ALL Panel test is typically delivered within 7-10 days.
Method and Test Type
The test is performed using cell culture and MLPA techniques. It falls under the category of genetics tests.
Doctor and Test Department
This test can be referred by a gynecologist. It is conducted in the genetics test department.
Pre Test Information
The Ped. ALL Panel – Karyotyping + MLPA Deletion/Duplication + FISH Panel test can be done with a doctor’s prescription. However, the prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.
We hope this article provided you with valuable information about the Ped. ALL Panel test. If you have any further questions or would like to schedule an appointment, please feel free to contact DNA Labs UAE.
Test Name | Ped. ALL Panel – Karyotyping and MLPA DeletionDuplication and FISH Panel Test |
---|---|
Components | EDTA & Sodium Heparin Vacutainer (2-3 ml. each) |
Price | 4800.0 AED |
Sample Condition | Peripheral Blood or Bone Marrow |
Report Delivery | 7-10 days |
Method | Cell culture+ MLPA |
Test type | Genetics |
Doctor | Gynecologist |
Test Department: | |
Pre Test Information | Ped. ALL Panel – Karyotyping + MLPA Deletion/Duplication + FISH Panel can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
Test Details |
The Ped. ALL Panel is a diagnostic test used to detect genetic abnormalities in children with acute lymphoblastic leukemia (ALL). The panel includes three different tests: karyotyping, MLPA deletion/duplication analysis, and FISH panel analysis. Karyotyping is a test that examines the chromosomes in a patient’s cells to look for any abnormalities or changes in the number or structure of the chromosomes. This test can detect large deletions or duplications of genetic material that may be associated with ALL. MLPA deletion/duplication analysis is a test that uses a specific technique called Multiplex Ligation-dependent Probe Amplification (MLPA) to detect smaller deletions or duplications of genetic material that may be missed by karyotyping. This test can detect genetic abnormalities in specific genes that are known to be associated with ALL. FISH panel analysis is a test that uses fluorescent probes to detect specific genetic abnormalities in the chromosomes of a patient’s cells. This test can detect small changes in the DNA sequence that may be associated with ALL. By combining these three tests, the Ped. ALL Panel can provide a comprehensive analysis of a patient’s genetic makeup and help identify any genetic abnormalities that may be contributing to the development of ALL. This information can be used to guide treatment decisions and improve outcomes for children with this disease. |